NEW YORK, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:SLQT). Investors who purchased SelectQuote securities prior to September 9, 2020, and continue to hold to the present, are encouraged to obtain additional information […]
NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against F5, Inc. ("F5" or the "Company") (NASDAQ:FFIV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Charming Medical Ltd. ("Charming" or the "Company") (NASDAQ:MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against SLM Corporation ("SLM" or the "Company") (NASDAQ:SLM) and certain officers.�� The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-18834, is
NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methode Electronics, Inc. ("Methode Electronics" or "the Company") (NYSE:MEI). Investors who purchased Methode Electronics securities prior to December 2, 2021, and continue to hold to the present, are encouraged
NEW YORK, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Gauzy Ltd. ("Gauzy" or the "Company") (NASDAQ:GAUZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ:BBNX). Investors who purchased Beta Bionics securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s
New York, New York–(Newsfile Corp. – January 18, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DeFi Technologies, Inc. (NASDAQ: DEFT) between May 12, 2025 and November 14, 2025, both dates inclusive (the “Class Period”), of the important January 30, 2026 lead plaintiff deadline. SO WHAT:
NEW YORK, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ:UCTT). Investors who purchased Ultra Clean securities prior to May 6, 2024, and continue to hold to the present, are encouraged